TOP NEWS
ELECTION FIGHTS
BANKING & SECURITIES
IP & TECHNOLOGY
MEDIA & ENTERTAINMENT
TRANSPORTATION & INFRASTRUCTURE
REAL ESTATE
EMPLOYMENT & BENEFITS
Fed. Circ. Backs EPA's Firing Of 'Disruptive' Whistleblower
By Gina Kim
The Federal Circuit upheld a decision finding the U.S. Environmental Protection Agency would've fired a federal employee even if she wasn't whistleblowing on its failure to submit affirmative employment plans, ruling Wednesday that while there was significant motive to retaliate, there's also evidence the employee was "disrespectful, disruptive and discourteous" toward colleagues.
Opinion attached |
Read full article »
| Save to favorites »
COMPETITION
CYBERSECURITY & PRIVACY
CONSUMER PROTECTION
PERSONAL INJURY & MEDICAL MALPRACTICE
PRODUCT LIABILITY
INTERNATIONAL TRADE
TAX
BANKRUPTCY
IMMIGRATION
WHITE COLLAR
NATIVE AMERICAN
TELECOMMUNICATIONS
CANNABIS
PEOPLE
EXPERT ANALYSIS
Focusing On Fluoride: From FDA To Class Action
A class action filed two days after the U.S. Food and Drug Administration announced plans to remove ingestible fluoride prescription drug products for children from the market may be the tip of the iceberg in terms of the connection between government pronouncements on safety and their immediate use as evidence in lawsuits, says Rachel Turow at Skadden.
Complaint attached |
Read full article »
| Save to favorites »
LEGAL INDUSTRY
Kirkland Stops Repping Novartis After Regeneron Sought DQ
By Bryan Koenig
A New York federal judge accepted the withdrawal Thursday of the entire Kirkland & Ellis LLP team that recently joined Novartis Pharma's legal team battling antitrust allegations over the eye medication Eylea, just a week after plaintiff Regeneron Pharmaceuticals sought their disqualification over an "unthinkable" conflict of interest by the lawyers, whose firm previously represented Regeneron.
2 documents attached |
Read full article »
| Save to favorites »
|